Greatly Health Raises $4 Million Seed Round to Expand Access to Integrative Cancer Care
Greatly Health, a New York-based health technology company focused on expanding access to evidence-based integrative oncology care, has raised $4 million in seed funding to accelerate the growth of its virtual cancer care platform. The seed round was co-led by Pear VC and Commonweal Ventures, with participation from Flare Capital Partners and a group of strategic investors. The company said the new capital will support the expansion of its technology platform, grow its clinical team, and broaden access to research-backed supportive therapies for patients undergoing cancer treatment and survivorship.
Founded in 2025 by digital health executive Chip Stine alongside Memorial Sloan Kettering Cancer Center leaders Dr. Jun Mao and Dr. Robert Daly, Greatly Health is building a virtual care platform that integrates evidence-based supportive therapies directly into the cancer treatment journey. The company aims to make integrative oncology more widely available by delivering personalized care plans that complement conventional cancer treatments through digital technology.
Greatly Health’s platform combines one-on-one health coaching, live and on-demand group classes, symptom management, and a community experience designed specifically for people living with cancer and survivors. The program incorporates therapies including exercise, nutrition, mindfulness, meditation, yoga, and other evidence-based interventions that have been shown to reduce treatment-related side effects while improving patients’ physical and emotional well-being. By making these services available virtually, the company seeks to overcome access barriers that have traditionally limited integrative oncology programs to major academic medical centers.
The company’s care model builds on clinical research conducted at Memorial Sloan Kettering Cancer Center, where integrative medicine programs have demonstrated meaningful improvements in patient outcomes. According to Greatly Health, research supporting its approach found reductions in hospitalization rates and hospital stay durations while helping patients better manage symptoms such as pain, fatigue, anxiety, and depression. Company leaders believe broader access to these interventions can improve treatment adherence and overall quality of life for people receiving cancer care.
Chief Executive Officer Chip Stine said the funding will enable Greatly Health to scale a model that has already demonstrated measurable clinical benefits while making integrative oncology accessible to significantly more patients. Rather than replacing traditional oncology services, the platform is designed to work alongside physicians and existing treatment plans by providing evidence-based supportive care that addresses the physical, mental, and emotional challenges associated with cancer treatment.
The investment reflects growing interest in digital health platforms that combine virtual care delivery with clinically validated outcomes. As healthcare providers and insurers continue searching for ways to improve patient outcomes while reducing avoidable hospital utilization, supportive care models have attracted increasing attention. Greatly Health believes technology can help standardize access to integrative oncology services that have historically been available only through select cancer centers with specialized clinical teams.
The new funding will be used to enhance Greatly Health’s virtual technology platform, expand its internal clinical organization, and increase the range of evidence-based therapies available through the service. The company also plans to strengthen partnerships with health plans, healthcare providers, and life sciences organizations interested in integrating supportive oncology care into broader treatment pathways. Through these collaborations, Greatly aims to reach larger patient populations while maintaining the evidence-based clinical standards established by its founding team.
The company’s platform is intended to benefit multiple stakeholders across the healthcare ecosystem. Patients receive personalized supportive care designed to reduce symptom burden, healthcare providers gain access to scalable integrative medicine resources without increasing operational complexity, and health plans may benefit from improved patient outcomes and lower utilization of acute care services. Greatly believes this alignment creates a sustainable model for expanding access to comprehensive cancer care while addressing rising healthcare costs.
Investor support from Pear VC, Commonweal Ventures, Flare Capital Partners, and strategic investors underscores confidence in the company’s mission to modernize supportive oncology through digital innovation. As demand grows for whole-person approaches to cancer treatment, Greatly Health plans to continue investing in its clinical platform, technology infrastructure, and provider partnerships. With fresh seed capital, the company aims to establish integrative oncology as a more accessible and routine component of cancer care, enabling patients across the United States to benefit from research-backed supportive therapies regardless of their location or treatment setting.
